Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Wellbeing Digital Sciences Inc KONEF

Wellbeing Digital Sciences Inc. is a Canada-based mental healthcare company. The Company is focused on the development and implementation of clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. It operates through three segments: Wellbeing & IRP; KGK Science and Mindscape. It operates medical clinics across North America to help its patients access plant-based medicines, psychedelics, and other forms of mental health care, all of which have the potential to heal them of their physical and/or emotional pain. Its subsidiaries include Mindscape Ketamine & Infusions Therapy LLC, KGK Science Inc. and Integrated Rehab and Performance Ltd. It is also supported by a network of North American clinics that provide therapies and other types of treatment to patients as well as through a contract research organization that offers clinical trials services with a focus on nutraceutical and emerging health care products.


GREY:KONEF - Post by User

Post by StockHawk1on Dec 30, 2021 4:59pm
170 Views
Post# 34272218

$MEDI DD and financial update

$MEDI DD and financial update

Been feeling good about KetamineOne ( $MEDI $KONEF ) since they released their latest financial update. 


If you haven't heard of $MEDI it is a medical clinic company that owns a network of clinics across North America many of which specialize in ketamine mental health treatment. 


$MEDI also owns KGK Science Inc. which is a clinical research company that focuses on expanding knowledge on cannabis, ketamine and other emerging psychedelic treatments.


The update was for their first quarter of 2022 (aka Q122) which ended October 31st, 2021.


In Q122 $MEDI's assets equated to $19.08M. 


The revenue made was $1. 99M which in the same quarter last year was $nil.


Gross profit in Q121 was $nil but grew to $594k Q122. 


$MEDI had a lot of green days this week but closed stable today @ $0.30 


MC $31.005M


https://ca.finance.yahoo.com/news/ketamine-one-reports-strong-1q22-080000368.html

 
<< Previous
Bullboard Posts
Next >>